| Meng Dong Tan |
Founder of Moxian, Inc., Meng Dong Tan is a businessperson who has been at the helm of 9 different companies and holds the position of Chairman & Chief Executive Officer for 8i Acquisition 2 Corp., Chief Executive Officer & Director at 8i Capital Pte Ltd., Chief Executive Officer & Director at 8i Capital Ltd. and Chief Executive Officer & Director at 8i Enterprises Acquisition Corp. Mr. Tan is also on the board of Bright Growth Capital Ltd., 8i Enterprises Pte Ltd. (former Chief Executive Officer & Director) and Good Eastern Investment Holdings Ltd.
Mr. Tan previously held the position of Chairman & Chief Executive Officer at Incredible Holdings Ltd., Chairman, President & Chief Executive Officer at Moxian, Inc., Chairman & Chief Executive Officer for 8i Enterprises Acquisition Corp. and Chief Executive Officer & Director at Vantage Corp. Ltd.
Meng Dong Tan received an undergraduate degree from National University of Singapore. |
| Guan Hong Yap |
Founder of Cataya Pte Ltd., Guan Hong Yap presently is Chief Financial Officer & Director at 8i Acquisition 2 Corp. He is also on the board of Elve Ceramcrete Pte Ltd. and Lushwell Pte Ltd. and Member of CFA Institute.
In his past career he occupied the position of Head-Investment Banking at Shanghai Pingmei Shenma Finance Leasing Pte Ltd., Independent Director at Moxian, Inc., Chief Financial Officer & Director at 8i Enterprises Acquisition Corp. and Director at Cataya Pte Ltd.
He received an undergraduate degree from the University of Oxford. |
| Alexander K. Arrow |
Founder of Rindex Medical, Inc., Alexander K. Arrow currently holds the position of Chief Executive Officer & Director at Rindex Medical, Inc., Chief Executive Officer & Director at Lab Nine, Inc., Chief Financial Officer for Protagenic Therapeutics, Inc., Chief Financial Officer for Carlsmed, Inc. and Director & Operations Consultant at Zelegent, Inc. He is also on the board of Paragonix Technologies, Inc. and 8i Acquisition 2 Corp.
In the past he occupied the position of President, COO, Director & Chief Medical Officer at BIOLASE, Inc., Chief Operating Officer & Director at Neumedicines, Inc., Chief Financial Officer & Medical Director at Arstasis, Inc., Chief Financial Officer at The Patent & License Exchange, Chief Strategic Officer at Circuit Therapeutics, Inc., Head-Medical Technology Research at Lazard Ltd., Chief Executive Officer & Director at Zelegent, Inc., Chief Financial Officer of PLX Systems, Inc., Chief Financial Officer of Atrinsic, Inc., Principal at Wedbush Securities, Inc., Principal at Ladenburg Thalmann & Co., Inc. and Senior Vice President at FM Partners Holdings LLC.
He received an undergraduate degree from Cornell University and a doctorate from Harvard Medical School. |
| Ajay Kumar Rajpal |
Ajay Kumar Rajpal is Member of Institute of Chartered Accountants in England & Wales and on the board of 11 other companies.
He previously held the position of Chief Financial Officer of Tricor Plc, Managing Director at Wenham Major Ltd. and Independent Director & Partner at Moxian, Inc. |
| Kwong Yeow Liew |
Kwong Yeow Liew is on the board of 8i Enterprises Pte Ltd. and 8i Acquisition 2 Corp. In the past Mr. Liew occupied the position of President, CEO, CFO, Director & CAO at Rebel Group, Inc., General Manager-China Plant at Aztech Singapore Pte Ltd. and Head-Operations of Phoenix Mecano S.E. Asia Pte Ltd. |
